Recent Updates
Recently added Catalysts
IMMP Negative Sentiment Score: 35/100

IMMUTEP LIMITED INVESTORS WITH LOSSES HAVE UNTIL JULY 6, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

Key Takeaway: Bernstein Liebhard LLP has announced a deadline of July 6, 2026, for investors of Immutep Limited to join a class action lawsuit related to alleged securities fraud. The lawsuit accuses the company and some of its senior officers of making materially false statements regarding its business operations and financial stability. Investors who purchased shares between March 24, 2025, and March 12, 2026, may be eligible to participate in the litigation. The allegations suggest that these misrepresentations led to artificially inflated stock prices, resulting in significant losses when the truth was revealed.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors may face significant financial losses due to alleged fraud.
  • Concerns over misleading statements affecting Immutep's stock performance.
  • Ongoing class action lawsuit could impact the company's reputation.

Full Press Release Details

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Immutep Limited (“Immutep” or the “Company”) (NASDAQ: IMMP) investors of the July 6, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
Should You Join The Immutep Class Action Lawsuit:
Do you, or did you, own shares of Immutep Limited (NASDAQ: IMMP)?
Did you purchase your shares between March 24, 2025 and March 12, 2026, inclusive?
Did you lose money in your investment in Immutep Limited?
If you purchased or acquired Immutep ADRs, and/or would like to discuss your legal rights and options please visit Immutep Limited Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
If you wish to serve as lead plaintiff for the Class, you must file papers by July 6, 2026. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
A lawsuit was filed on behalf of investors (the “Class”) who purchased or acquired the American Depositary Receipts (“ADRs”) of Immutep between March 24, 2025 and March 12, 2026, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.
The lawsuit alleges that defendants made materially false and misleading statements and omissions regarding the Company’s business operations, growth prospects, and financial stability. As a result of these alleged misrepresentations, Immutep ADRs traded at artificially inflated prices during the Class Period. When the truth was disclosed, investors allegedly suffered significant losses.
About Bernstein Liebhard:
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Tags

Frequently Asked Questions

What is the deadline for the Immutep class action lawsuit?

The deadline to join the Immutep class action lawsuit is July 6, 2026.

Who are eligible participants in the Immutep lawsuit?

Investors who purchased Immutep shares between March 24, 2025, and March 12, 2026.

Do I need to serve as lead plaintiff to recover losses?

No, you can recover without being a lead plaintiff; you may remain an absent class member.

What does the lawsuit allege against Immutep?

It claims Immutep made false statements about its business and financial stability.

Are there any fees to join the class action?

There are no fees or expenses for shareholders joining the class action.

Last updated: Jun 10, 2026